期刊文献+

单倍体相合造血干细胞移植联合间充质干细胞输注治疗异染性脑白质营养不良

Haploidentical Hematopoietic Stem Cell Transplantation and Mesenchymal Stem Cell Infusion for the Treatment of Metachromatic Leukodystrophy
下载PDF
导出
摘要 目的探讨单倍体相合造血干细胞移植联合间充质干细胞输注治疗异染性脑白质营养不良的疗效。方法 7岁患儿,采用单倍体相合造血干细胞移植联合间充质干细胞输注的方法,经氟达拉滨、马利兰、环磷酰胺和抗人胸腺细胞球蛋白方案进行预处理,供者应用G-CSF动员和联合免疫抑制剂(包括环胞菌素A、氨甲喋呤、霉酚酸酯、CD25单抗)预防移植物抗宿主病。造血重建后,每周输注脐带来源的间充质干细胞1次,连续4周。结果患儿造血重建迅速,11 d时中性粒细胞>0.5×109/L、血小板>20×109/L;14 d时血白细胞芳基硫酸酯酶A水平明显上升;28 d时达正常水平。患者无急性GVHD发生。移植后1个月经植入证据检测,证实为完全供者造血,神经系统症状逐渐恢复。结论单倍体相合造血干细胞移植,联合间充质干细胞输注,治疗异染性脑白质营养不良,安全、有效,血白细胞芳基硫酸酯酶A水平回升迅速。这种新型疗法可能是治疗缺乏HLA全相合供者的异染性脑白质营养不良疾病患者的可靠选择。 Objective To investigate the effect of haploidentical hematopoietic stem cell transplantation and mesenchymal stem cell infusion in the treatment of metachromatic leukodystrophy.Methods A 7-year-old girl with metachromatic leukodystrophy received hematopoietic stem cell transplantation and mesenchymal stem cells infusion.The pretreatment regimen consisted of fludarabine,cyclophosphamide,and busulfan.The prophylaxis of acute graft-versus-host disease was performed by the administration of anti-CD25 monoclonal antibody,cyclosporine A,methotrexate,mycophenolate mofetil,anti-thymocyte globulin and G-CSF-mobilized bone marrow.After hematopoietic reconstruction,mesenchymal stem cells derived from umbilical cord were intravenously infused once a week for 4 consecutive weeks.Results The patient achieved rapid hematopoietic engraftment of donor origin.Neutrophil( 0.5 × 10^9 / L) and platelet( 20 × 10^9 / L) recovery was achieved on +11 day.On day 14,arylsulfatase A level in peripheral blood leukocytes was significantly increased and it reached to the normal range on +28 day.No acute graft-versus-host disease was observed.One month after transplantation,finger-printing analysis indicated an achievement of complete donor-type hematopoiesis.Neurological symptoms gradually recovered.Conclusion Haploidentical hematopoietic stem cell transplantation and mesenchymal stem cell infusion for the treatment of metachromatic leukodystrophy were safe,effective and leukocyte arylsulfatase A level rises rapidly.The novel regimen described here might be one of the options patients with metachromatic leukodystrophy and lack of HLA-matched sources.
出处 《组织工程与重建外科杂志》 2010年第5期253-256,共4页 Journal of Tissue Engineering and Reconstructive Surgery
基金 首都发展基金重点项目(2007-2033) 国家高技术研究发展计划(863项目)(2007AA02Z454)
关键词 造血干细胞移植 单倍体相合 间充质干细胞 异染性脑白质营养不良 Hematopoietic stem cell transplantation Haploidentical Mesenchymal stem cells Metachromatic leukodystrophy
  • 相关文献

参考文献15

  • 1Wang H,Wang Z,Xue M,et al.Co-transfusion of haplo-identical hematopoietic and mesenehymal stromal cells to treat a patient with severe aplastic[J].Cytotherapy,2010,12(4):563-565.
  • 2Avanzini MA,Bernardo ME,Cometa AM,et al.Generation of mesenchymal stromal cells in the presence of platelet lysate:a phenotypie and functional comparison of umbilical cord blood and bone marrow-derived progenitors[J].Haematologica,2009,94 (12):1649-1660.
  • 3Boeleas JJ.Trends in haematopoietic cell transplantation for inborn errors of metabolism[J].J Inherit Metab Dis,2006,29(2-3):413-420.
  • 4Sauer M,Grewal S,Peters C.Hematopoietic stem cell transplantation for mucopolysaceharidoses and leukodystrophies[J].Klin Padiatr,2004,216(3):163-168.
  • 5Gorg M,Wilck W,Granitzny B,et al.Stabilization of juvenile metachromatic leukodystrophy after bone marrow transplantation:a 13-year follow-up[J].J Child Neurol,2007,22(9):1139-1142.
  • 6Pierson TM,Bonnemann CG,Finkel RS,et al.Umbilical cord blood transplantation for juvenile metachrometic leukodystrophy[J].Ann Neurol,2008,64(5):583-587.
  • 7Bredius RG,Laan LA,Lankester AC,et al.Early marrow transplantation in a pre-symptomatic neonate with late infantile metachromatic leukodystrophy does not halt disease progression[J].Bone Marrow Transplant,2007,39(5):309-310.
  • 8Keating A.Mesenchymal swomal cell[J].Curr Opin Hematol,2006,13(6):419-425.
  • 9侯瑞琴,王婧,孔圆,陈育红,黄晓军,曾洋,葛健,刘全华,赵春华,刘开彦.单倍体相合造血干细胞移植联合间充质干细胞输注对患者造血微环境的影响[J].中国实验血液学杂志,2010,18(1):155-160. 被引量:11
  • 10Muller L Kustermann KB,Holzwanrth C,et al.In vitro analysis of multipotent mesenehymai stroma cells as potential cellular therapeutics in neurometabolic diseases in pediatric patients[J].Exp Hematol,2006,34(10):1413-1419.

二级参考文献19

  • 1黄晓军,韩伟,许兰平,陈欢,刘代红,陈育红,江倩,路瑾,刘开彦,任汉云,陆道培.HLA配型不合情况下造血干细胞移植的新方法[J].北京大学学报(医学版),2004,36(3):229-233. 被引量:26
  • 2Deans R J, Moseley AB. Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol, 2000 ; 28 (8) : 875 - 884.
  • 3Huang XJ, Liu DH, Liu KY, et al. Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies. Bone marrow transplan- tation, 2006,38(4) : 291 -297.
  • 4Cao J, Tan MH, Yang P, et aL Effects of adjuvant chemotherapy on bone marrow mesenchymal stem cells of colorectal cancer patients. Cancer Lett, 2008, 263 (2) : 197 - 203.
  • 5Almeida-Porada G, Porada CD, Tran N, et al. Cotransplantation of human stromal cell progenitors into preimmune fetal sheep results in early appearance of human donor cells in circulation and boosts cell levels in bone marrow at later time points after transplantation. Blood, 2000 ; 95 ( 11 ) : 3620 - 3627.
  • 6In't Anker PS, Noort WA, Kruisselbrink AB, et al. Nonexpanded primary lung and bone marrow-derived mesenchymal ceils promote the engraftment of umbilical cord blood-derived CD34 ( + ) cells in NOD/SCID mice. Exp Hematol,2003; 31(10) : 881 -889.
  • 7Kim DW, Chung YG, Kim TG, et al. Cotransplantation of thirdparty mesenchymal stromal cells can alleviate single-donor predominance and increase engraftment from double cord transplan- tation. Blood,2004,103 (5) : 1t941 - 1948.
  • 8Koc ON, Gerson L, Cooper BW, et al. Rapid hematopoietic recovery after coinfusion of autologotts blood stem ceils and culture expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high dose chemotherapy. J Clin Oncol, 2000; 18 (2) : 307 -316.
  • 9Lazarus HM, Koc ON, Devine SM, et al. Cotransplantation of HLA-identical sibling culture expanded mesenchymal stem ceils and haematopoietic stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant, 2005 ; 11 ( 5 ) : 389 - 398.
  • 10Lee ST, Jang JH, Cheong JW, et al. Treatment of high-risk acute myelogenous leukaemia by myeloablative chemoradiotherapy followed by co-infusion of T cell-depleted haematopoietic stem cells and culture-expanded marrow mesenchymal stem cells from a related donor with one fully mismatched human leucocyte antigen haplotype. Br J Haematol, 2002;118(4) :1128 -1131.

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部